Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 131   

Articles published

NVO 44.87 -1.05 (-2.29%)
price chart
Novo Nordisk A/S (ADR) Price Target Update
Novo Nordisk A/S (ADR) (NYSE:NVO): According to 1 Analysts, The short term target price has been estimated at $ 56.66.
Bullish and Outperform S&P 500: Novo Nordisk A/S (ADR) , Fidelity ...  Ashburn Daily
Investors Sell Novo Nordisk A/S (ADR) on Price Strength
Novo Nordisk A/S (ADR) (NYSE:NVO) surged 0.69% during the last session. The last traded price was up 0.31 points at $45.47.
Sanofi Still Ahead Of Novo Nordisk In Insulin Drug Race
Novo Nordisk A/S (ADR) (NVO) announced yesterday, that its insulin therapy Tresiba, which was in late-stage trials, has proved to be safe and effective for the treatment of type 1 diabetes in children and young adults.
Related articles »  
Is Novo Nordisk A/S (ADR) (NVO) Going to Burn These Hedge Funds?
Out of the hedge funds we follow, Renaissance Technologies, managed by Jim Simons, holds the largest position in Novo Nordisk A/S (ADR) (NYSE:NVO). Renaissance Technologies has a $433.1 million position in the stock, comprising 1.1% of its 13F ...
Related articles »  
In A World of Cheap Oil, Europe Looks Good [iShares MSCI Sweden Index (ETF ...
europe Martin Hutchinson: The halving in oil prices is the biggest economic change we have seen since the 2008 financial crash. There are winners and losers everywhere from it, but there's one standout winner: the European Union, which produces only ...
Novo Nordisk A/S (ADR) (NVO) news: Novo Nordisk A/S Management ...
Good day, and welcome to the Q4 2013 Novo Nordisk A/S Earnings Conference Call, hosted by CEO Lars Rebien S�rensen. Today's call is being recorded.
Related articles »  
MannKind Corporation (MNKD), Novo Nordisk A/S (ADR) (NVO), Eli Lilly & Co ...
Doctors like to see patients get their A1c levels below 7%, but the portion of the patients who reached the target was higher in the group taking Novo Nordisk A/S (ADR) (NYSE:NVO)'s injected insulin Novolog than the Afrezza group. The proportion ...
Related articles »  
Novo Nordisk A/S (ADR) (NVO): Insiders Aren't Crazy About It
Novo Nordisk A/S (ADR) (NYSE:NVO) was in 13 hedge funds' portfolio at the end of the first quarter of 2013. NVO shareholders have witnessed a decrease in support from the world's most elite money managers lately.
Novo Nordisk A/S: Stock split information
The trading unit of the Novo Nordisk B shares listed on the stock exchange in Copenhagen will be changed from DKK 1 to DKK 0.20.
Related articles »  
Hedge Funds Are Selling Novo Nordisk A/S (ADR) (NYSE:NVO) - Forest ...
Is Novo Nordisk A/S (ADR) (NYSE:NVO) ready to raly soon? Money managers are turning less bullish. The number of long hedge fund positions retreated by 1 lately.
Related articles »